Annual Accounts Payable
$2.58 M
+$2.32 M+890.77%
31 December 2023
Summary:
Day One Biopharmaceuticals annual accounts payable is currently $2.58 million, with the most recent change of +$2.32 million (+890.77%) on 31 December 2023. During the last 3 years, it has risen by +$2.37 million (+1175.25%). DAWN annual accounts payable is now at all-time high.DAWN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$3.02 M
-$3.43 M-53.18%
30 September 2024
Summary:
Day One Biopharmaceuticals quarterly accounts payable is currently $3.02 million, with the most recent change of -$3.43 million (-53.18%) on 30 September 2024. Over the past year, it has dropped by -$374.00 thousand (-11.03%). DAWN quarterly accounts payable is now -53.18% below its all-time high of $6.44 million, reached on 30 June 2024.DAWN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DAWN Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +890.8% | -11.0% |
| 3 y3 years | +1175.3% | +341.7% |
| 5 y5 years | - | - |
DAWN Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1175.3% | -53.2% | +1060.4% |
| 5 y | 5 years | at high | +3633.3% | -53.2% | +1393.6% |
| alltime | all time | at high | +3633.3% | -53.2% | +1393.6% |
Day One Biopharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.02 M(-53.2%) |
| June 2024 | - | $6.44 M(+34.8%) |
| Mar 2024 | - | $4.78 M(+85.6%) |
| Dec 2023 | $2.58 M(+890.8%) | $2.58 M(-24.0%) |
| Sept 2023 | - | $3.39 M(-25.7%) |
| June 2023 | - | $4.57 M(-2.0%) |
| Mar 2023 | - | $4.66 M(+1691.2%) |
| Dec 2022 | $260.00 K | $260.00 K(-93.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $3.97 M(+805.0%) |
| June 2022 | - | $439.00 K(-37.4%) |
| Mar 2022 | - | $701.00 K(-59.8%) |
| Dec 2021 | $1.74 M(+763.4%) | $1.74 M(+155.3%) |
| Sept 2021 | - | $683.00 K(+96.3%) |
| June 2021 | - | $348.00 K(-49.3%) |
| Mar 2021 | - | $686.00 K(+239.6%) |
| Dec 2020 | $202.00 K(+192.8%) | $202.00 K |
| Dec 2019 | $69.00 K | - |
FAQ
- What is Day One Biopharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual accounts payable year-on-year change?
- What is Day One Biopharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly accounts payable year-on-year change?
What is Day One Biopharmaceuticals annual accounts payable?
The current annual accounts payable of DAWN is $2.58 M
What is the all time high annual accounts payable for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual accounts payable is $2.58 M
What is Day One Biopharmaceuticals annual accounts payable year-on-year change?
Over the past year, DAWN annual accounts payable has changed by +$2.32 M (+890.77%)
What is Day One Biopharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of DAWN is $3.02 M
What is the all time high quarterly accounts payable for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly accounts payable is $6.44 M
What is Day One Biopharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, DAWN quarterly accounts payable has changed by -$374.00 K (-11.03%)